📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

PLCG1 is required for AML1-ETO leukemia stem cell self-renewal. (2022)

First Author: Schnoeder TM

Attributed to: Finding therapeutic targets in FLT3-ITD AML using a systems biology approach funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2021012778

PubMed Identifier: 34695195

Publication URI: http://europepmc.org/abstract/MED/34695195

Type: Journal Article/Review

Volume: 139

Parent Publication: Blood

Issue: 7

ISSN: 0006-4971